AJP - Heart Watch the video to learn how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 297: H153-H162, 2009. First published May 8, 2009; doi:10.1152/ajpheart.01142.2008
0363-6135/09 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Buy
Right arrow All Versions of this Article:
297/1/H153    most recent
01142.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Serpillon, S.
Right arrow Articles by Gupte, S. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Serpillon, S.
Right arrow Articles by Gupte, S. A.

Superoxide production by NAD(P)H oxidase and mitochondria is increased in genetically obese and hyperglycemic rat heart and aorta before the development of cardiac dysfunction. The role of glucose-6-phosphate dehydrogenase-derived NADPH

Sabrina Serpillon,1,* Beverly C. Floyd,* Rakhee S. Gupte,1,2 Shimran George,1 Mark Kozicky,1 Venessa Neito,1 Fabio Recchia,1 William Stanley,3 Michael S. Wolin,1 and Sachin A. Gupte1,2

1Department of Physiology, New York Medical College, Valhalla, New York; 2Department of Biochemistry, University of South Alabama, College of Medicine, Mobile, Alabama; and 3Department of Medicine, Division of Cardiology, University of Maryland, Baltimore, Maryland

Submitted 28 October 2008 ; accepted in final form 4 May 2009

Increased oxidative stress is a known cause of cardiac dysfunction in animals and patients with diabetes, but the sources of reactive oxygen species [e.g., superoxide anion (O2)] and the mechanisms underlying O2 production in diabetic hearts are not clearly understood. Our aim was to determine whether NADPH oxidase (Nox) is a source of O2 and whether glucose-6-phosphate dehydrogenase (G6PD)-derived NADPH plays a role in augmenting O2 generation in diabetes. We assessed cardiac function, Nox and G6PD activities, NADPH levels, and the activities of antioxidant enzymes in heart homogenates from young (9–11 wk old) Zucker lean and obese (fa/fa) rats. We found that myocardial G6PD activity was significantly higher in fa/fa than in lean rats, whereas superoxide dismutase and glutathione peroxidase activities were decreased (P < 0.05). O2 levels were elevated (70–90%; P < 0.05) in the diabetic heart, and this elevation was blocked by the Nox inhibitor gp-91ds-tat (50 µM) or by the mitochondrial respiratory chain inhibitors antimycin (10 µM) and rotenone (50 µM). Inhibition of G6PD by 6-aminonicotinamide (5 mM) and dihydroepiandrosterone (100 µM) also reduced (P < 0.05) O2 production. Notably, the activities of Nox and G6PD in the fa/fa rat heart were inhibited by chelerythrine, a protein kinase C inhibitor. Although we detected no changes in stroke volume, cardiac output, or ejection fraction, left ventricular diameter was slightly increased during diastole and systole, and left ventricular posterior wall thickness was decreased during systole (P < 0.05) in Zucker fa/fa rats. Our findings suggest that in a model of severe hyperlipidema and hyperglycemia Nox-derived O2 generation in the myocardium is fueled by elevated levels of G6PD-derived NADPH. Similar mechanisms were found to activate O2 production and induce endothelial dysfunction in aorta. Thus G6PD may be a useful therapeutic target for treating the cardiovascular disease associated with type 2 diabetes, if second-generation drugs specifically reducing the activity of G6PD to near normal levels are developed.

pentose phosphate pathway; protein kinase C; adenylate cyclase; cardiac function



Address for reprint requests and other correspondence: S. A. Gupte, Dept. of Biochemistry and Molecular Biology, Univ. of South Alabama, College of Medicine, 307 University Blvd. N., Mobile, AL 36688 (e-mail: sachin_gupte{at}yahoo.com)




This article has been cited by other articles:


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
D. J. Chess, R. J. Khairallah, K. M. O'Shea, W. Xu, and W. C. Stanley
A high-fat diet increases adiposity but maintains mitochondrial oxidative enzymes without affecting development of heart failure with pressure overload
Am J Physiol Heart Circ Physiol, November 1, 2009; 297(5): H1585 - H1593.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2009 by the American Physiological Society.